References
- PerfectJRCoxGMLeeJYThe impact of culture isolation of Aspergillus species: A hospital-based survey of aspergillosisClin Infect Dis2001331824183311692293
- WalshTJAnaissieEJDenningDWTreatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of AmericaClin Infect Dis20084632736018177225
- RelloJEsandiMEMariscalDGallegoMDomingoCVallesJInvasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and reviewClin Infect Dis199826147314759636889
- AderFNseirSLe BerreRInvasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogenClin Microbiol Infect20051142742915882191
- BulpaPDiveASibilleYInvasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseaseEur Respir J20073078280017906086
- SamarakoonPSoubaniAOInvasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literatureChron Respir Dis20085192718303098
- MeerssemanWLagrouKMaertensJVan WijngaerdenEInvasive aspergillosis in the intensive care unitClin Infect Dis20074520521617578780
- BouzaEGuineaJPeláezTPérez-MolinaJAlcaláLMunozPWorkload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospitalJ Clin Microbiol2005432075207915872225
- RabeKFHurdSAnzuetoAGlobal Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Crit Care Respir Med2007176532555
- YuVLMuderRRPoorsattarASignificance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective studyAm J Med1986812492543090879
- SteinbachWJStevensDAReview of newer antifungal and immuno-modulatory strategies for invasive aspergillosisClin Infect Dis200337Suppl 3S15718712975751
- PattersonTFKirkpatrickWRWhiteMInvasive aspergillosis Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study GroupMedicine (Baltimore)200079250260
- LinSJSchranzJTeutschSMAspergillosis case-fatality rate: systematic review of the literatureClin Infect Dis20013235836611170942
- RoosenJFransEWilmerAKnockaertDCBobbaersHComparison of premortem clinical diagnoses in critically iII patients and subsequent autopsy findingsMayo Clin Proc20007556256710852416
- DimopoulosGPiagnerelliMBerreJEddafaliBSalmonIVincentJLDisseminated aspergillosis in intensive care unit patients: an autopsy studyJ Chemother200315717512678418
- GuineaMTorres-NarbonaPGijonTPelaezPMunozJDe MiguelEBouzaEInvasive pulmonary aspergillosis in patients with COPD: A description of 57 cases collected in a single tertiary hospital (1999–2008). Abstract M-2161Washington, D.C48th ICAAC/IDSA 46th Annual MeetingOctober 25–28, 2008
- UptonAKirbyKACarpenterPBoeckhMMarrKAInvasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortalityClin Infect Dis20074453154017243056
- RomaniLImmunity to fungal infectionsNat Immunol20044113
- LandboCPrescottELangePVestboJAlmdalTPPrognostic value of nutritional status in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19991601856186110588597
- SeidlerMJSalvenmoserSMüllerFMCAspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cellsAntimicrob Ag Chemoter20085241304136
- SchaffnerATherapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferonJ Clin Invest198576175517643932471
- DiamondRDInhibition of monocyte-mediated damage to fungal hyphae by steroid hormonesJ Infect Dis19831471606822752
- NgTTCRobsonGDDenningDWHydrocortisone enhanced growth of Aspergillus spp: implications for pathogenesisMicrobiology1994140247524797952197
- PeterEBakriFBallDMCheneyRTSegalBHInvasive pulmonary filamentous fungal infection in a patient receiving inhaled corticosteroid therapyClin Infect Dis2002365456
- BaroukyRBadetMSaint DenisMSoubirouJLPhilitFGuerinCInhaled corticosteroids in COPD and disseminated aspergillosisEur J Int Med200314380382
- CornetMHallatHSommeDFulminant invasive pulmonary aspergillosis in immunocompetent patients. A two-case reportClin Microbiol Infect200391224122714686988
- HarteminkKJPaulMASpijkstraJJGirbesARJPoldermanKHImmunoparalysis as a cause of invasive aspergillosisInt Care Med20032920682071
- De PauwBWalshTJDonnellyJPRevised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClin Infect Dis2008461813182118462102
- JantunenEPiilonenAVolinLDiagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipientsBone Marrow Transplant20002586787110808208
- KahnFWJonesJMEnglandDMThe role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosisAm J Clin Pathol1986865185232429543
- AndreasSHeindlSWattkyCMöllerKRüchelRDiagnosis of pulmonary aspergillosis using optical brightenersEur Respir J20001540741110706512
- CaillotDMannoneLCuisenierBCouaillierJFRole of early diagnosis and aggressive surgery in the management of invasive pulmonary asper-gillosis in neutropenic patientsClin Microbiol Infect20017546111525219
- HorvathJADummerSThe use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosisAm J Med19961001711788629651
- KaiserLHugueninTLewPDChapuisBPittetDInvasive aspergillosis Clinical features of 35 proven cases at a single institutionMedicine (Baltimore)1998771881949653430
- LevyHHorakDATegtmeierBRYokotaSBFormanSJThe value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosisRespir Med1992862432481620912
- DenningDWRiniotisKDobrashianRSambatakouHChronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and revewClin Infect Dis200337S3S26528012975754
- MaertensJVerhaegenJLagrouKVan EldereJBoogaertsMScreening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validationBlood2001971604161011238098
- PfeifferCDFineJPSafdarNDiagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysisClin Infect Dis2006421417142716619154
- MeerssemanWVandecasteeleSJWilmerAVerbekenEPeetermansWEVan WijngaerdenEInvasive aspergillosis in critically ill patients without malignancyAm J Respir Crit Care Med200417062162515229094
- SanguinettiMPosteraroBPaganoLComparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosisJ Clin Microbiol2003413922392512904419
- MusherBFredricksDLeisenringWBalajeeSASmithCMarrKAAspergillus galactomannan enzymenimmunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluidJ Clin Microbiol2004425517552215583275
- SeyfarthHJNenoffPWinklerJKrahlRHausteinUFSchauerJAspergillus detection in bronchoscopically acquired material. Significance and interpretationMycoses20014435636011766098
- ClancyCJJaberRALeatherHLBronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipientsJ Clin Microbiol2007451759176517428933
- MeerssemanWLagrouKMaertensJGalactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patientsAm J Respir Crit Care Med2008177273417885264
- AnsorgRVan den BoomRRathPMDetection of Aspergillus galactomannan antigen in foods and antibioticsMycoses1997403533579470421
- SulahianATouratierSRibaudPFalse positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactamN Engl J Med20033492366236714668472
- ViscoliCMachettiMCappellanoPFalse-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin–tazobactamClin Infect Dis20043891391614999640
- BeckerMJDeMSFensMHVerbrughHABakker-WoudenbergIAEffect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosisJ Antimicrob Chemother20035242843412917249
- MarrKALaverdiereMGugelALeisenringWAntifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassayClin Infect Dis2005401762176915909264
- Ostrosky-ZeichnerLAlexanderBDKettDHMulticenter clinical evaluation of the [1–> 3]-β-D-glucan assay as an aid to diagnosis of fungal infections in humansClin Infect Dis20054165465916080087
- OkadaSTeramotoSTakizawaHOuchiYMatsuokaRClinical insignificance of 1–> 3]-β-D-glucan in early diagnosis of invasive pulmonary aspergillosis in a patient with chronic obstructive pulmonary diseaseJ Med Microb20035210311032
- VandewoudeKHVogelaersDBlotSIAspergillosis in the ICU-the new 21st century problemMed Mycol200644S7176
- DigbyJKalbfleischJGlennALarsenABrowderWWilliamsDSerum glucan levels are not specific for presence of fungal infections in intensive care unit patientsClin Diagn Lab Immunol20031088288512965921
- SkladnyHBuchheidtDBaustCSpecific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCRJ Clin Microbiol1999373865387110565898
- BretagneSCostaJMMarmorat-KhuongADetection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCRJ Clin Microbiol199533116411687615723
- RaadIHannaHSumozaDAlbitarMPolymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patientsCancer2002941032103611920473
- RaadIHannaHHuaringaASumozaDHachemRAlbitarMDiagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of Aspergillus in BALChest20021211171117611948049
- BuchheidtDBaustCSkladnyHBaldusMBrauningerSHehlmannRClinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patientsBr J Haematol200211680381111886384
- WhitePLLintonCJPerryMDJohnsonEMBarnesRAThe evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical settingClin Infect Dis20064247948616421791
- MengoliCCrucianiMBarnesRALoefflerJDonnellyPUse of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysisLancet Infect Dis20099899619179225
- HopeWWWalshTJDenningDWLaboratory diagnosis of invasive aspergillosisLancet Infect Dis2005560962216183515
- GarciaMEBlancoJLCaballeroJGargallo-ViolaDAnticoagulants interfere with PCR used to diagnose invasive aspergillosisJ Clin Microbiol2002401567156811923400
- CollinsJCT signs and patterns of lung diseaseRadiol Clin North Am2001391115113511699664
- CaillotDCouaillierJFBernardAIncreasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropeniaJ Clin Oncol20011925325911134220
- GreeneRThe radiological spectrum of pulmonary aspergillosisMed Mycol200543S14715416110807
- HorgerMEinseleHSchumacherUInvasive pulmonary aspergillosis: frequency and meaning of the “hypodense sign” on unenhanced CTBr J Radiol20057869770316046420
- KamiMKishiYHamakiTThe value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis. An autopsy-based retrospective study of 48 patientsMycoses20024528729412572717
- LeeYRChoiYWLeeKJJeonSCParkCKHeoJNCT halo sign: the spectrum of pulmonary diseasesBr J Radiol20057886286516110114
- PasmansHLLoosveldOJSchoutenHCThunnissenFvan EngelshovenJMInvasive aspergillosis in immunocompromised patients: findings on plain film and (HR) CTEur J Radiol19921437401563402
- WonHJLeeKSCheonJEInvasive pulmonary aspergillosis: prediction at thin-section CT in patients with neutropenia – a prospective studyRadiology19982087777829722859
- PintoPSThe CT halo signRadiology20042303740
- VandewoudeKHBlotSIBenoitDColardynFVogelaersDInvasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependenceJ Hosp Infect20045626927615066736
- GreeneRESchlammHTStarkPRadiological findings in acute invasive pulmonary aspergillosis: utility and reliability of halo sign and air crescent sign for diagnosis and treatment of invasive pulmonary aspergillosis in high-risk patients [abstract]European Congress of Microbiology and Infectious Diseases, 13th annual meeting2003
- HerbrechtRDenningDWPattersonTFVoriconazole versus amphotericin B for primary therapy of invasive aspergillosisN Engl J Med200234740841512167683
- ChandrasekarPHCurtrightJManavathuEEfficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig modelJ Antimicrob Chemother20004567367610797091
- KirkpatrickWRMcAteeRKFothergillAWRinaldiMGPattersonTFEfficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosisAntimicrob Agents Chemother2000502865286810991875
- TakemotoKYamamotoYUedaYKanazawaKYoshidaKNikiYComparative study on the sfficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis modelChemotherapy20095510511319151551
- ZoniosDIBennettJEUpdate on azole antifungalsSemin Respir Crit Care Med20082919821018366001
- DrusanoGLHow does a patient maximally benefit from anti-infective chemotherapyClin Infect Dis2004391245124615486851
- LewisREWhat is the “therapeutic range” for voriconazoleClin Infect Dis20084621221418171252
- BoydAEModiSHowardSJMooreCBKeevilBGDenningDWAdverse reactions to voriconazoleClin Infect Dis2004391241124415486850
- BalianJDSukhovaNHarrisJWThe hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population studyClin Pharmacol Ther1995576626697781266
- LutsarIHodgesMRTomaszewskiKTrokePFWoodNDSafety of voriconazole and dose individualizationClin Infect Dis2003361087108812684928
- PascualACalandraTBolaySBuclinTBilleJMarchettiOVoriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomesClin Infect Dis20084620121118171251
- LevêqueDNivoixYJehlFHerbrechtRClinical pharmacokinetics of voriconazoleInt J Antimicrob Agents20062727428416563707
- ZoniosDIGea-BanaclocheJChildsRBennettJEHallucinations during voriconazole therapyClin Infect Dis200847e7e1018491963
- BoucherHWGrollAHChiouCCWalshTJNewer systemic antifungal agents: pharmacokinetics, safety and efficacyDrugs2004641997202015341494